Geovax Labs Inc (GOVX)

Jan 02, 2025

Contrasting GeoVax Labs (NASDAQ:GOVX) & Silverback Therapeutics (NASDAQ:SBTX) - Defense World

Jan 02, 2025

Dec 31, 2024

GeoVax Labs, Inc. (NASDAQ:GOVX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Dec 31, 2024

Dec 18, 2024

GeoVax adjourns Special Meeting due to low quorum - Investing.com

Dec 18, 2024

Dec 18, 2024

GeoVax adjourns Special Meeting due to low quorum By Investing.com - Investing.com Australia

Dec 18, 2024

Dec 09, 2024

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - The Manila Times

Dec 09, 2024

Dec 09, 2024

GeoVax Labs Secures Key Cancer Vaccine Patent, Reports Breakthrough 100% Tumor Prevention Data - StockTitan

Dec 09, 2024

Dec 08, 2024

GeoVax Labs (GOVX) Price Target Increased by 1170.83% to 77.78 - MSN

Dec 08, 2024

Dec 06, 2024

GeoVax Labs, Inc. (NASDAQ:GOVX) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Dec 06, 2024

Dec 02, 2024

Geovax Labs (FRA:E8LA) Days Inventory : 0.00 (As of Sep. 2024) - GuruFocus.com

Dec 02, 2024

Nov 30, 2024

Geovax Labs (STU:E8LA) Forward Dividend Yield % : 0.00% (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

Nov 30, 2024

Alliance Global Partners Initiates Coverage of GeoVax Labs (GOVX) with Buy Recommendation - MSN

Nov 30, 2024

Nov 29, 2024

3 Penny Stocks Ready to Break Out in 2025 - sharewise

Nov 29, 2024

Nov 29, 2024

Geovax Labs (GOVX-Q) QuotePress Release - The Globe and Mail

Nov 29, 2024

Nov 27, 2024

Geovax Labs (STU:E8LA) Momentum Rank : 5 (As of Nov. 27, 2024) - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewswire

Nov 26, 2024

Nov 26, 2024

GeoVax CEO to Present COVID-19 Vaccine & Cancer Therapy Updates at NobleCon20 | GOVX Stock News - StockTitan

Nov 26, 2024

Nov 23, 2024

GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks - MSN

Nov 23, 2024

Nov 23, 2024

Q4 EPS Estimates for GeoVax Labs Lifted by Noble Financial - Defense World

Nov 23, 2024

Nov 20, 2024

GeoVax Announces Positive Interim Data Review for Phase 2 - GlobeNewswire

Nov 20, 2024

Nov 19, 2024

GeoVax regains compliance with Nasdaq listing standards By Investing.com - Investing.com Australia

Nov 19, 2024

Nov 19, 2024

GeoVax regains compliance with Nasdaq listing standards - Investing.com India

Nov 19, 2024

Nov 19, 2024

GeoVax reports progress in CLL vaccine booster trial - Investing.com India

Nov 19, 2024

Nov 19, 2024

GeoVax reports progress in CLL vaccine booster trial By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 19, 2024

GeoVax Labs announces interim data from Phase 2 trial of Vaccine technology - TipRanks

Nov 19, 2024

Nov 19, 2024

GeoVax's COVID Booster Shows Promise in Leukemia Patients, Outperforms mRNA Vaccine | GOVX Stock News - StockTitan

Nov 19, 2024

Nov 19, 2024

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia - The Manila Times

Nov 19, 2024

Nov 16, 2024

Analysts Set Expectations for GeoVax Labs FY2024 Earnings - Defense World

Nov 16, 2024

Nov 15, 2024

Earnings call: GeoVax reports progress in vaccine trials, financial updates By Investing.com - Investing.com Australia

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Expands Stake in Geovax Labs Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Brokerages Set GeoVax Labs, Inc. (NASDAQ:GOVX) PT at $12.67 - Defense World

Nov 14, 2024

Nov 13, 2024

GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2024 Earnings Call Transcript - MSN

Nov 13, 2024

Nov 13, 2024

Earnings call: GeoVax reports progress in vaccine trials, financial updates - Investing.com

Nov 13, 2024

Nov 13, 2024

U.S. Stock market top losers: Gaucho Group Holdings sees decline of 55.06% while GeoVax Labs looses 23.53% in early trading - Business Upturn

Nov 13, 2024

Nov 13, 2024

Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges - Yahoo Finance

Nov 13, 2024

Nov 13, 2024

Alliance Global Partners Initiates Coverage on GeoVax Labs (NASDAQ:GOVX) - Defense World

Nov 13, 2024

Nov 12, 2024

GeoVax Labs Reports Improved Earnings and Strategic Progress - TipRanks

Nov 12, 2024

Nov 12, 2024

GeoVax Labs reports Q3 EPS (91c), consensus ($1.48) - TipRanks

Nov 12, 2024

Nov 12, 2024

GeoVax Reports Progress on COVID-19 Vaccine and Cancer Therapies in Q3 2024 Financial Results - Citybuzz

Nov 12, 2024

Nov 12, 2024

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

GeoVax Q3 Loss Narrows to $5.8M as BARDA Contract Boosts Revenue to $2.8M | GOVX Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

GeoVax Labs initiated with a Buy at Alliance Global Partners - Yahoo Finance

Nov 12, 2024

Nov 11, 2024

This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday - Benzinga

Nov 11, 2024

Nov 06, 2024

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewswire

Nov 06, 2024

Oct 22, 2024

Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross? - MSN

Oct 22, 2024

Oct 17, 2024

GeoVax expands offering size to $30 million By Investing.com - Investing.com Australia

Oct 17, 2024

Oct 17, 2024

GeoVax expands offering size to $30 million - Investing.com India

Oct 17, 2024